SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andriy Turhovach who wrote (5678)9/28/1998 10:51:00 AM
From: Rocketman  Read Replies (1) of 9719
 
Wouldn't surprise me at all. They are way undervalued for a company with as much cash in the bank, guaranteed revenue, future royalty streams, and annual growth rate as they have. The main reason it tanked recently was due to some big funds and momentum investors dumping millions of shares at any price and nothing to do with fundamental changes in the business. What does surprise me is that they did this given (as I recall it) Roy Whitfield's negative attitude towards these types of moves. I would be really surprised if this was his idea. Sounds like someone else on the board driving it, but I also can't see him stopping the board from doing it or making a big deal out of it. Notice that unlike virtually every press release that ever came out of INCY that there is no Roy Whitfield quote included in this one - hmmmmmm??? They may have even been driven to do this by pharma partners who don't want any other pharma taking over their consortium. What I really like is the Pfizer deal announced today too.

Rman

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext